Women in STEM

Decades of Male-Focused Medical Research Could Bias Healthcare AI

PUBLISHED 9/21/2026 by and

Many people will learn CPR using a flat-chested manikin. A 2024 study of 20 models of CPR manikins sold worldwide found that three-quarters were described as male or had no sex specified. Of the 20, only one offered a breast overlay.

The manikins reflect a wider tendency in medical teaching and research to treat the male body as standard. The terms “male and female” and “men and women” in this article reflect the sources, which often fail to distinguish sex from gender or say whether gender-diverse people were included.

The lack of female representation can have consequences. In a U.S. study of 19,331 out-of-hospital cardiac arrests, 39 percent of women who collapsed in public received bystander CPR, compared with 45 percent of men.

Medical research is becoming more representative, but much of today’s evidence was collected when male bodies were more often treated as standard. Careful design could help AI identify patterns that older research missed.

As tomorrow’s healthcare is built from yesterday’s records, researchers must ask whether an apparent difference reflects biology or the way patients encountered healthcare. Otherwise old assumptions could become embedded in new technology.

Menopause Is a Public Policy Story. Congress Must Treat It Like One.

PUBLISHED 9/16/2026 by

On Wednesday, Sept. 16, I testified before the U.S. Senate Special Committee on Aging at Congress’ first-ever hearing devoted to menopause. I am an attorney, advocate and author whose primary professional focus is menstruation, menopause and the law—an unusual sphere of expertise, I know. These experiences too often go neglected and are deeply deserving of public policy attention and intervention.

Menopause is a whole-body transition affecting women’s immediate and long-term physical, cognitive, mental and metabolic health. Too often, women navigate these changes without the support they need.

In the United States, about 1.3 million women enter menopause each year—roughly 6,000 per day. Yet there are only around 4,000 certified menopause practitioners across the country, and menopause care deserts are common, especially in rural areas and across the South and Midwest.

Menopause is an individual and collective health story. But it also is a marriage and family story. A career and economic story. An aging and longevity story. And most certainly, a public policy story. There is no singular reform that will respond to every scenario or address every challenge facing every woman in midlife. But a collection of proposals already on the table in Congress, under consideration at federal agencies and advancing in statehouses offer a meaningful start.

(This essay is adapted from the written testimony Jennifer Weiss-Wolf submitted to the U.S. Senate Special Committee on Aging for its Sept. 16 hearing, “Half the Country, Zero Hearings: Meeting the Moment to End the Menopause Care Gap in America”—Congress’ first-ever hearing devoted to menopause.)

Half the Country, a Fraction of the Research

PUBLISHED 9/15/2026 by | UPDATED 9/29/2026 at 11:49 A.M. PT

For decades, Democratic and Republican administrations alike presided over a medical research system that routinely excluded women. The result? Modern medicine was built on incomplete science—and women are still paying the price. 

It wasn’t until the NIH Revitalization Act of 1993 that federally funded clinical trials were required to include women. Yet changing who participates in research does not rewrite decades of medical knowledge overnight. By then, physicians had already been trained using male-centered evidence, diagnostic standards had been established, and countless drugs had already been dosed using evidence derived solely from men.  

In 2025, the Trump administration has proposed cutting the NIH’s budget by roughly 43 percent (equivalent to $20 billion per year). Its broader HHS budget proposal called for eliminating or consolidating several programs supporting family planning and maternal and child health. Federal agencies also came under pressure to scrutinize or reject grant proposals containing terms such as women, leading to paused or cancelled fellowships and research on conditions such as uterine fibroids and pregnancy. 

There are signs, however, that Congress may finally be beginning to treat women’s health across the lifespan as a serious policy issue.

On Sept. 16, the Senate Special Committee on Aging will hold Congress’ first-ever hearing devoted to menopause. Led by ranking member Sen. Kirsten Gillibrand (D-N.Y.), “Half the Country, Zero Hearings: Meeting the Moment to End the Menopause Care Gap in America” will examine the nation’s lack of menopause research, informed medical care and provider training—and make the case for greater federal investment.

The hearing represents an overdue step forward. But women’s health cannot remain vulnerable to political cycles. Regardless of which party holds power, it must become a permanent priority within American policy and medicine.

‘That’s Just Aging’ Is Not a Diagnosis

PUBLISHED 8/28/2026 by

As a physician, I was trained with the same mantra: that hormone therapy was only for women who were absolutely miserable, and that if we were to prescribe it, it was for the least amount of time at the smallest dose.

That was completely wrong.

In 2002, part of the Women’s Health Initiative study was halted prematurely for a press release that essentially stated that hormone therapy caused breast cancer—when in actuality, the women who took estrogen alone (those without a uterus) actually had a reduced risk for breast cancer.

The mangling of that messaging is in large part responsible for scaring a generation of physicians off prescribing hormone therapy and terrifying generations of women away from taking the very things—estrogen and progesterone—that improve the immediate symptoms of menopause (such as hot flashes, night sweats, vaginal dryness and recurrent UTIs) and prevent the long-term consequences of estrogen depletion like osteoporosis, heart disease and premature cognitive decline.

Every time you refuse to accept a doctor telling you, “That’s just aging,” you aren’t just advocating for yourself. You’re doing structural work. You’re demanding to be seen as a full person, not as a set of body parts.

The questions women ask in exam rooms are how the gap between medical evidence and clinical practice closes. It’s how we close the disparity between men’s health and women’s health.

Health, after all, isn’t about having all the answers. It’s about asking better questions—of yourself, and of the people responsible for your care.

Mifepristone, Mail-In Voting and the Midterms Are All on the Line

PUBLISHED 8/22/2026 by

Trump has officially nominated Dr. Heidi Overton as the FDA commissioner. Overton previously called the abortion pill “telebortion,” and called on Congress to strictly regulate it.

With the FDA currently reevaluating its approval of mifepristone and its regulations permitting providers to mail the medication, Overton’s nomination represents yet another challenge to mifepristone’s widespread usage—accounting for over two-thirds of all abortions, including in states with bans. Not to mention the fact that Overton also recently appeared next to Trump during a press conference in which he spouted dangerous misinformation about childhood vaccines.

Asking for a friend: Will the physician in the Senate who holds a key vote on the Health Committee cave again?

Meanwhile, the Supreme Court might be on summer break—but its shadow docket is still up and running. And nothing is certain before this Supreme Court, which has committed itself to expanding Trump’s executive powers.

Thanks to SCOTUS and state legislators’ rollback of many fundamental rights, state supreme court races have been receiving increased attention, and attracted significant outside spending.

What the Lindsay Clancy Trial Reveals About America’s Failure to Support Mothers in Crisis

PUBLISHED 8/21/2026 by

News of Lindsay Clancy’s triple-murder trial is flooding the Internet, and with it, conversations about postpartum depression. In January 2023, Lindsay Clancy killed her 5-year-old, 3-year-old and 8-month-old children before attempting suicide, which left her paralyzed from the waist down. The facts of their deaths are not up for debate in this Plymouth trial, but whether or not the severe postpartum psychosis, clinical depression and bipolar disorder Clancy was experiencing meant she was criminally insane. 

Clancy’s mother-in-law explained Clancy was “begging for help” right before she killed her children. In December, just weeks before, she told her mother and then-husband Patrick (the couple are now divorced) that “she had thoughts of harming the children.”

The case has laid bare the failures of a U.S. mental healthcare system that did not protect Clancy or her children, and still leaves countless new mothers without adequate care.

While Clancy stands trial, people are mourning the loss of Hayden Panettiere, a child star who had long struggled with postpartum depression following the 2014 birth of her daughter, Kaya, and experienced domestic violence from her ex-boyfriend Brian Hickerson. This week, news outlets revisited Panettiere’s allegation that Neutrogena (one of her long-time partners) attempted to end her contract after she spoke honestly about her postpartum depression.

My Hysterectomy Was a Gift. Dr. Kemi Doll Shows Why Women Need to Share Our ‘Womb Stories’

PUBLISHED 8/8/2026 by

Determined to prevent uterine cancer deaths, Dr. Doll published A Terrible Strength: The Hidden Crisis of the Black Womb and Your Survival Guide to Healing in May. Both comprehensive and compassionate, the book focuses on individuals of African descent, showing how everyone will benefit.

Upon finishing A Terrible Strength, I took its message to heart: One need not have a womb to prioritize womb health. We can all join Kemi Doll’s Womb Sisterhood through the “deliberate telling and sharing” of “womb stories” with “our true friends.” 

Fortunately, women have already started talking. Personal testimonies changed health outcomes in the 1970s and ’80s—and they’re doing the same now. Earlier generations suffered through perimenopause in silence, but today, women in their 20s, 30s and 40s hear about not only hot flashes but also itchy ears and frozen shoulders. And, as a woman in my early 50s, I’m not completely in the dark about hormone replacement therapy (HRT).

Nevertheless, deadly silence remains.

I am childfree by choice, so pregnancy never fueled my concerns, but I became preoccupied with gynecology in 2017. Fibroids were wreaking havoc in my life, and I pursued a hysterectomy to end my suffering. As Doll puts it, this “definitive treatment” is “welcomed by some and mourned by others.” Though I very much welcomed a hysterectomy, I couldn’t secure one until May 2021, despite my best efforts. 

From now on, I will participate in the “deliberate telling and sharing” of “womb stories.” Doing so is difficult but necessary. As Doll explains, sharing our experience requires us to “shift away from a strength that withstands suffering, silence and pain.” It requires, in her words, “a strength that embraces our vulnerability and can demand better care from the larger world.”

Who Will Train the Next Generation of Abortion Providers?

PUBLISHED 8/3/2026 by

Reproductive health clinics have been closing at alarming rates since the Supreme Court ended federal abortion protections in 2022. Every time a clinic closes, patients lose access to care, but that’s not all: Whole communities lose their comprehensive care providers for future generations.

As a nurse, doula and the executive director of the reproductive health clinical training and advocacy group Repro TLC, I’ve seen firsthand how abortion restrictions and clinic closures are shrinking the pipeline of trained providers. This is happening even in the states where access to abortion care remains fairly robust. 

The result is a workforce crisis in the medical field that extends far beyond abortion access and threatens the future of reproductive health in communities nationwide. 

Community-based reproductive health centers—clinics that operate independently of hospitals, major medical centers or Planned Parenthood affiliates—serve as a safety net for patients. They provide 58 percent of abortion care nationwide. 

They also provide crucial training infrastructure for future healthcare providers. Most medical and nursing education programs do not teach abortion care; providers who want to provide abortions to patients often have to find, coordinate and fund their own training opportunities at independent clinics—like a self-organized medical rotation. And as more of these independent clinics close, these training opportunities dwindle.

Who’s Paying the Price for Trump’s Medicaid Cuts? Communities of Color and People Living With HIV.

PUBLISHED 7/29/2026 by

President Trump and his Republican backers have been determined to gut the Affordable Care Act (ACA) and expanded Medicaid coverage ever since his first term in office. This year he is finally getting his way, putting the health of tens of millions of Americans at risk.

It is racial minorities and the chronically ill who will be the most harmed.

A year ago, Congress passed the so-called One Big Beautiful Bill Act, putting in place onerous new eligibility requirements for Medicaid coverage, including work requirements. Medicaid enrollees ages 19 to 64 must complete at least 80 hours a month of work, community service, job training or education to maintain coverage, unless they qualify for an exemption. All states must comply with the new rule by Jan. 1, 2027.

The combination of ACA cuts and new barriers to Medicaid enrollment will likely cause historic coverage losses across the United States for years to come, according to new research: Nearly 16 million people stand to lose coverage by 2034.

‘The Wrong Kind of Girl’: Feminists Warn of Fallout After Supreme Court Says States May Exclude Trans Girls From School Sports Teams

PUBLISHED 7/16/2026 by

The Supreme Court ruled 6-3 on Tuesday, June 30, that states may prohibit transgender students from participating in school sports consistent with their gender identity, holding that the Equal Protection Clause of the 14th Amendment does not prohibit such bans. The decision leaves in place laws already enacted in 27 states and marks another major setback for transgender rights after months of escalating attacks on LGBTQ+ communities.

Feminist organizations, reproductive justice advocates, physicians, civil rights leaders and lawmakers swiftly condemned the ruling, arguing that it harms transgender youth, undermines Title IX’s protections against sex discrimination and fits into a broader campaign targeting marginalized communities.

Human Rights Campaign president Kelley Robinson argued the ruling would fuel suspicion and harassment not only toward transgender athletes but toward girls more broadly.

“When politicians convince the public that any girl could be ‘the wrong kind of girl,’ they invite harassment, intimidation, invasive questioning or even an inspection of their body by a total stranger. While we know this administration and other anti-equality politicians won’t stop obsessing over trans kids, we must all call on states to adopt inclusive policies so that no one gets left behind for being their authentic selves. We must show up in large numbers for every school board, local and state and federal election to be sure our communities are heard. We must continue this fight with full force until freedom, justice and equal opportunity are not flimsy promises but nationwide guarantees.”